Cancer clinical trials in the region Île-de-France

312 currently recruiting clinical trials
Region Île-de-France

Early Access Lung cancer
NSCLC (Non-Small Cell Lung Cancer) Locally Advanced Metastatic EGFR Targeted therapy
Systemic Treatment-Naive
6 main criterias to confirm
Janssen
Early Access Lung cancer
NSCLC (Non-Small Cell Lung Cancer) Locally Advanced Metastatic EGFR None Systemic Treatment-Naive
7 main criterias to confirm
Janssen
Early Access Lung cancer
NSCLC (Non-Small Cell Lung Cancer) Non-squamous NSCLC Locally Advanced EGFR None Chemotherapy Radiotherapy
8 main criterias to confirm
AstraZeneca
Early Access Lung cancer
NSCLC (Non-Small Cell Lung Cancer) Localized ALK None Systemic Treatment-Naive Surgery
8 main criterias to confirm
Hoffmann-La Roche
Early Access Lung cancer
NSCLC (Non-Small Cell Lung Cancer) Localized PDL1 Positive (1% <= X < 25%) PDL1 Positive (25% <= X < 50%) PDL1 Positive (>= 50%) None Systemic Treatment-Naive
ALK EGFR
8 main criterias to confirm
Bristol-Myers Squibb
Early Access Lung cancer
SCLC (Small Cell Lung Cancer) Localized Locally Advanced None Chemotherapy Radiotherapy Chemotherapy Radiotherapy
7 main criterias to confirm
AstraZeneca
Phase 3 Breast cancer
#NCT04961996
HER2 Negative HR Positive Localized
6 main criterias to confirm
Hôpital Saint Louis AP-HP (Paris)
Hoffmann-La Roche
Phase 3 Pancreas cancer
#NCT06608927
Adenocarcinoma Metastatic None Systemic Treatment-Naive
7 main criterias to confirm
Gustave Roussy (Villejuif)
Arcus Biosciences
Phase 3 Prostate cancer
#NCT06625970
Adenocarcinoma Localized PSMA PET Negative None Systemic Treatment-Naive
Surgery Radiotherapy Internal Vectorised Radiotherapy (IVR)
9 main criterias to confirm
Gustave Roussy (Villejuif)
UNICANCER